Nathan Seligson

Passionate pharmacist; asst professor @UFPharmacy; #PrecisionMedicine clinician @Nemours. Opinions=mine. #Sarcoma #scmsm #Oncopharm #TwitterRx

[UF Health Cancer Institute @UFHealthCancer]

Five @UF researchers have been selected for our 2024 @AmericanCancer Society Institutional Research Grant Pilot Projects! These grants support our early-stage investigators in #cancer-related research studies.

Learn more about their projects: https://t.co/6hb0o3R7rS

[FDA Oncology @FDAOncology]

FDA approves safety labeling changes regarding DPD deficiency for fluorouracil injection products.
https://t.co/Hrdk9zkRx7

#OCENewsBurst

[UF Pharmacy @UFPharmacy]

Dr. Mohammed Gbadamosi has secured an Early Independence Award from the @NIH to launch his independent research career. He is one of only 13 junior scientists nationally to receive an Early Independence Award in 2023. https://t.co/vwSDaEfRX9

[UF Pharmacy @UFPharmacy]

Dr. Anthony M. Casapao is one of only 12 pharmacists worldwide to be elected as a 2023 Fellow of the @IDSAInfo (Infectious Diseases Society of America). https://t.co/tCNkH4rS2N

[Brett Baskovich, MD @drdoubleb]

The study guide you never knew you needed: all the soft tissue translocations I could fit into Lose Yourself by Eminem #PathParody @YamatoSueMitsu

[John Ligon, M.D. @JohnLigon]

The Ligon lab and Pediatric Cancer Immunotherapy Initiative (PCI2) at UF is hiring a highly motivated veterinary technician! Come join the fight to beat pediatric cancer! https://t.co/vU13QZ3hAd

[Nathan Seligson @nathanseligson]

Integrating pharmacogenomic testing into paired germline/somatic genomic testing can be an efficient method for increasing access to testing. In this perspective, my co-authors and I argue for this approach to extend #PGx testing for patients with cancer. https://t.co/KpSNAVQYVX

[Katelynn Granger, PharmD, BCOP @KG_PharmD]

Know someone on the hunt for a PGY2 in Oncology or Transplant?? @MUSCPharmRes is looking for a candidate in each specialty- join us tonight to learn more!

Links can be found here: https://t.co/yIuS5RLIFb

[Karen Sweiss @KarenSweiss]

MM and BMT folks: did you know there is 500% variation in high dose melphalan plasma exposure among MM patients undergoing ASCT? How is it acceptable that we deliver such an extremely important drug in such an unreliable way? Test dose strategies have failed but....

[Jeffrey West @mathoncbro]

🚨Postdoctoral Fellow Job🚨

Eagerly accepting applications for a postdoc position in my group:
https://t.co/FvWkQNubA0

Come join the dynamic and exciting research environment in the IMO (@mathonco) department!

[Nathan Seligson @nathanseligson]

So proud of my @UFPharmacy students presenting their work at @ctosociety. #ProudPI

[Nathan Seligson @nathanseligson]

On the plane to #CTOS2022! Excited to be back in person for this excellent meeting.

[Jonathan Licht, MD @jdlicht]

Congrats to @UFHealthCancer member @KileyGraim of @UFCISE, who has received a grant from @theNCI to build a first-of-its-kind database and study genomic information from a range of animals to gain insight into the mechanisms of rare human #cancers: https://t.co/L7wgjOxOcz

[Nathan Seligson @nathanseligson]

I am grateful to the @AACPharmacy PGx SIG for their support of our work educating future precision medicine experts at @UFPharmacy. I was unable to attend this year but hope I get to see everyone in 2023! #TwitteRx

[Lakesha Butler @DrladyButler]

Beginning a new chapter soon @UFHealth, so honored and grateful. UF Health chief diversity officer named, begins Aug. 22 https://t.co/pOusPvXs3Y

[Ben Nacev, MD PhD @BenNacev]

Our latest work is out in @NatureComms. With @fsanchezvega, @WTapMD, Samuel Singer, and colleagues at @MSKSarcoma
@MSKCancerCenter, we present a genomic analysis of 2,138 tumors representing 45 subtypes of soft tissue and bone #sarcoma (1/x). 🧵

https://t.co/t5dwktvDuy

[Jon Trent, MD, PhD @JTrentMDPhD]

@HuangLabICR discussing homologous recombination and sensitivity to temozolomide plus olaparib in pts with uterine #leiomyosarcoma from clinical trial samples. #sarcoma #ASCO22

[Razelle Kurzrock, MD @Dr_R_Kurzrock]

All patients had complete response. Treat early. Repeat. Treat early. It’s CML all over again. PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer | NEJM: https://t.co/uZQFITXkU3